More about

Eosinophilic Esophagitis

News
October 31, 2023
2 min read
Save

Maternal, infant antibiotic use associated with increased eosinophilic esophagitis risk

Maternal, infant antibiotic use associated with increased eosinophilic esophagitis risk

Maternal and infant antibiotic use was associated with increased eosinophilic esophagitis risk in a study published in JAMA Pediatrics.

News
October 20, 2023
1 min read
Save

Top in allergy/asthma: Updates on epinephrine nasal spray, dupilumab

Top in allergy/asthma: Updates on epinephrine nasal spray, dupilumab

Responses to epinephrine nasal spray were comparable to those from injected epinephrine, researchers said.

News
October 11, 2023
4 min read
Save

Q&A: Study safely increases peptide doses to treat eosinophilic esophagitis

Q&A: Study safely increases peptide doses to treat eosinophilic esophagitis

Healthy volunteers taking a first-in-class peptide designed for treating eosinophilic esophagitis did not experience any clinically significant adverse safety findings at any of three evaluated doses, according to a press release.

News
October 09, 2023
3 min read
Save

Patients with both asthma, eosinophilic esophagitis experience earlier hospital visits

Patients with both asthma, eosinophilic esophagitis experience earlier hospital visits

HONOLULU — Patients with both eosinophilic esophagitis and asthma present to the hospital at an earlier age than those patients who only have EoE, according to an abstract presented at the CHEST Annual Meeting.

News
September 29, 2023
1 min read
Save

Top in allergy/asthma: FDA needs more data on nasal spray; what patients with asthma want

Top in allergy/asthma: FDA needs more data on nasal spray; what patients with asthma want

The FDA asked ARS Pharma for additional testing of its epinephrin nasal spray neffy, which was developed to treat type 1 allergic reactions, before the agency makes a decision regarding the company’s new drug application.

News
September 28, 2023
3 min read
Save

FDA grants priority review to dupilumab for pediatric eosinophilic esophagitis

FDA grants priority review to dupilumab for pediatric eosinophilic esophagitis

The FDA has granted priority review to a supplemental biologics license application for dupilumab in the treatment of children aged 1 to 11 years with eosinophilic esophagitis, according to a press release.

News
September 18, 2023
3 min read
Save

Lack of timely follow-up care common among patients with eosinophilic esophagitis

Lack of timely follow-up care common among patients with eosinophilic esophagitis

Adults with eosinophilic esophagitis often failed to return to their specialist for timely follow-up care, according to a letter published in Annals of Allergy, Asthma & Immunology.

News
August 31, 2023
3 min read
Save

Eosinophilic esophagitis presentation, care vary by race, socioeconomics in children

Eosinophilic esophagitis presentation, care vary by race, socioeconomics in children

Children diagnosed with eosinophilic esophagitis were predominantly white, non-Hispanic and English speaking, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
August 22, 2023
4 min read
Save

Targeting IL-18 may improve treatment for eosinophilic esophagitis

Targeting IL-18 may improve treatment for eosinophilic esophagitis

Inhibiting the NLRP3 pathway and the release of IL-18 may prevent the development of eosinophilic esophagitis, according to a study published in Nature’s Communications Biology.

News
August 09, 2023
1 min watch
Save

VIDEO: Physician assistants conference addresses eosinophilic esophagitis, chronic cough

VIDEO: Physician assistants conference addresses eosinophilic esophagitis, chronic cough

PARK CITY, Utah — The state of care in eosinophilic esophagitis and chronic cough were among the topics at the Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology Conference.

View more